Is Testosterone Replacement Therapy Safe For Aging Men?

Donna Krupa
(301) 634-7209
dkrupa@the-aps.org


Is Testosterone Replacement Therapy Safe For Aging Men?

Austin, TX – For decades, older women have taken hormone replacements to replenish estrogen and progesterone levels lost to aging. More recently, testosterone (the most important male hormone) supplements have been used by aging men to improve their muscle mass, bone strength, libido and quality of life. In 2002, the number of elderly American men taking testosterone replacement therapy was nearly 819,000, and the number is growing. The increased use has occurred despite the fact that the cardiovascular effects of chronic testosterone treatment in aging males are largely unknown, and the safety of testosterone replacement has not been evaluated.

– For decades, older women have taken hormone replacements to replenish estrogen and progesterone levels lost to aging. More recently, testosterone (the most important male hormone) supplements have been used by aging men to improve their muscle mass, bone strength, libido and quality of life. In 2002, the number of elderly American men taking testosterone replacement therapy was nearly 819,000, and the number is growing. The increased use has occurred despite the fact that the cardiovascular effects of chronic testosterone treatment in aging males are largely unknown, and the safety of testosterone replacement has not been evaluated.

A team of researchers has been using an animal model to investigate potential links between testosterone supplements and cardiovascular and renal disease. The team, comprised of Radu Iliescu, Licy L. Yanes, Julio C. Sartori-Valinotti, and Jane F. Reckelhoff, is affiliated with the University of Mississippi Medical Center’s Department of Physiology and Biophysics, Jackson, MS. Their most recent study and an overview of data from other human and animal studies is part of the upcoming conference, Sex and Gender in Cardiovascular-Renal Physiology and Pathophysiology. The meeting, sponsored by The American Physiological Society (APS; www.The-APS.org), is being held August 9-12, 2007 at the Hyatt Regency Austin on Town Lake, Austin, TX.

Latest Study

The team is presenting its work entitled, “Testosterone Supplements Promote Renal Injury and Exacerbate Hypertension in Aging Spontaneously Hypertensive Rats (SHR),” in which spontaneously hypertensive rats were used as a model for genetic hypertension.

Three groups of rats were used: intact, gonadectomized (at eight months of age), and testosterone-supplemented rats. Testosterone supplements were administered chronically via pellets and rats were monitored until 13 months of age. Blood pressure was measured at the end of the experiment via indwelling arterial catheters inserted into conscious, freely moving rats. Urine was collected for two hours and urinary protein excretion was determined.  

The researchers found that blood pressure was significantly higher in testosterone-supplemented male SHR as compared with intact rats, whereas castration did not alter blood pressure levels.  Testosterone supplemented SHR excreted more urinary protein than intact rats, and castration reduced proteinuria (urinary protein).  

The results suggest that testosterone supplementation of aging male SHR promotes renal injury and thereby exacerbates hypertension. The results also show that removal of endogenous androgens later in life (eight months) prevents the development of hypertensive renal injury without altering existing hypertension levels.

The Big Picture

The study is part of the researchers’ ongoing project to investigate the effects of testosterone-supplementation in animal models of disease that mimic the characteristics of the human male population that currently receive testosterone supplements. They are currently testing the hypotheses that the natural decrease in testosterone brought on by aging may affect the progression of pre-existing cardiovascular/renal disease.


Related Items

Chromium Picolinate May Lessen Inflammation in Diabetic Nephropathy

Released September 22, 2010 - Taking chromium picolinate may help lessen inflammation associated with kidney disease is the conclusion of a study comparing diabetic mice treated with chromium picolinate with those that received placebo. Mice who received the supplement had lower levels of albuminuria (protein in the urine), an indication of kidney disease. Untreated diabetic mice had marked immunostaining for interleukin 6 (IL-6) and interleukin 17 (IL-1 and moderate immunostaining for indolamine 2,3-dioxygenase (IDO), an immunoregulatory enzyme that modulates the production of IL-6 and IL-17.

In Heart Disease, Men and Women are Different

Released August 15, 2011 - When it comes to heart disease, men and women are different. Our October 2011 conference focuses on the role of gender in cardiovascular disease, a disease that kills more women than breast cancer.

Gender Matters in Heart Health

Released September 28, 2011 - Highlights of the upcoming meeting, “Physiology of Cardiovascular Disease: Gender Disparities”

Women’s Heart Disease Tied to Small Blood Vessels

Released October 14, 2011 - Bairey Merz, MD provides an overview of latest data about methods and how they can be applied to help clinicians understand gender differences in the pathophysiology of heart disease.

Testosterone Replacement Therapy (TRT) Beneficial In Men 60 And Older

Released April 7, 2008 - In one of the first clinical trials involving men over 60-85 years of age, researchers’ preliminary results indicate that testosterone treatment for five months has a positive effect on the bone markers of older men.

From: 
Email:  
To: 
Email:  
Subject: 
Message:

~/Custom.Templates/Document2Columns.aspx